Introduction：Basic information about CAS 141410-98-2|Edobacomab, including its chemical name, molecular formula, synonyms, physicochemical properties, and safety information, etc.
| Common Name | Edobacomab |
|---|
| CAS Number | 141410-98-2 | Molecular Weight | / |
|---|
| Density | / | Boiling Point | / |
|---|
| Molecular Formula | / | Melting Point | / |
|---|
| MSDS | / | Flash Point | / |
|---|
Names
Edobacomab BiologicalActivity
| Description | Edobacomab (E5) is a mouse anti-endotoxin monoclonal IgM antibody. Edobacomab ca be uesd for the research of sepsis caused by Gram-negative bacterial infections[1]. |
|---|
| Related Catalog | Research Areas >>InfectionSignaling Pathways >>Others >>Others |
|---|
| In Vitro | Prolgolimab can bind endotoxin and neutralize it with subsequent attenuate inflammatory response and improved outcome[2]. |
|---|
| References | [1]. Kobayashi H, et, al. [Phase I study of edobacomab (E5) in patients with gram-negative sepsis]. Kansenshogaku Zasshi. 1994 Jan;68(1):59-80. [2]. Angus DC, et, al. E5 murine monoclonal antiendotoxin antibody in gram-negative sepsis: a randomized controlled trial. E5 Study Investigators. JAMA. 2000 Apr 5;283(13):1723-30. |
|---|
Chemical & Physical Properties
| No Any Chemical & Physical Properties |
